Market closed
Haleon/HLN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5Y
About Haleon
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ticker
HLN
Sector
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Employees
25,408
Website
Haleon Metrics
BasicAdvanced
$47B
Market cap
66.81
P/E ratio
$0.15
EPS
0.16
Beta
$0.15
Dividend rate
2.04%
Dividend yield
Price and volume
Market cap
$47B
Beta
0.16
52-week high
$10.33
52-week low
$7.70
Average daily volume
4M
Dividend rate
$0.15
Financial strength
Current ratio
0.837
Quick ratio
0.489
Long term debt to equity
44.879
Total debt to equity
54.175
Dividend payout ratio (TTM)
50.92%
Interest coverage (TTM)
6.21%
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
6.82%
Valuation
Price to earnings (TTM)
66.811
Price to revenue (TTM)
6.439
Price to book
2.14
Price to tangible book (TTM)
-3.64
Price to free cash flow (TTM)
29.526
Dividend yield (TTM)
1.44%
Forward dividend yield
2.04%
Growth
Revenue change (TTM)
-1.31%
Earnings per share change (TTM)
-11.39%
What the Analysts think about Haleon
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Haleon stock.
Haleon Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Haleon Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Haleon News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Market closed
Upcoming events
Sept
19
Haleon
Dividend·Payment
$0.051416
Per share
FAQs
What’s the current market cap for Haleon stock?
Haleon (HLN) has a market cap of $47B as of September 09, 2024.
What is the P/E ratio for Haleon stock?
The price to earnings (P/E) ratio for Haleon (HLN) stock is 66.81 as of September 09, 2024.
Does Haleon stock pay dividends?
Yes, the Haleon (HLN) stock pays dividends to shareholders. As of September 09, 2024, the dividend rate is $0.14913 and the yield is 2.04%. Haleon has a payout ratio of 50.92% on a trailing twelve-month basis.
When is the next Haleon dividend payment date?
The next Haleon (HLN) dividend payment is scheduled for September 19, 2024.
What is the beta indicator for Haleon?
Haleon (HLN) has a beta rating of 0.16. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.